NOVARTIS INDIA LTD. - 500672 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited (''The Company'') Held Today I.E. Wednesday, November 09, 2022
Outcome of the Meeting of the Board of Directors of Novartis India Limited (''the Company'') held today i.e. Wednesday, November 09, 2022 NOVARTIS INDIA LTD. - 500672 - Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited (''The Company'') Held Today I.E. Wednesday, November 09, 2022
Outcome of the Meeting of the Board of Directors of Novartis India Limited (''the Company'') held today i.e. Wednesday, November 09, 2022 NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 NOVARTIS INDIA LTD. - 500672 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0770 Name of the Signatory :- Nikhil MalpaniDesignation :- Company Secretary and Compliance Officer NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 NOVARTIS INDIA LTD. - 500672 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate in terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2022 NOVARTIS INDIA LTD. - 500672 - Update on board meeting
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 ,inter alia, to consider and approve Update on board meeting to inter alia, consider and approve the Unaudited Financial Results of the Company for the second quarter and half year ending on September 30, 2022. NOVARTIS INDIA LTD. - 500672 - Closure of Trading Window
Intimation of meeting of the Board of Directors of Novartis India Limited and Closure of Trading Window NOVARTIS INDIA LTD. - 500672 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Second Quarter And Half Year Ending On September 30, 2022
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 ,inter alia, to consider and approve the Unaudited Financial Results for the second quarter and half year ending on September 30, 2022 NOVARTIS INDIA LTD. - 500672 - Closure of Trading Window
Intimation of meeting of the Board of Directors of Novartis India Limited and Closure of Trading Window